Clinical Trial Update: Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pantoprazole for peptic ulcer hemorrhage has completed, with Wyeth now a part of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Peptic Ulcer Hemorrhage | Phase 2 | Status: COMPLETED